Federation Des Caisses Desjardins Du Quebec Milestone Pharmaceuticals Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.4 Billion
- Q4 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 13,000 shares of MIST stock, worth $21,190. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,000
Previous 10,500
23.81%
Holding current value
$21,190
Previous $15,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding MIST
# of Institutions
51Shares Held
25.1MCall Options Held
61.2KPut Options Held
38.8K-
Black Rock Inc. New York, NY4.97MShares$8.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.7MShares$4.41 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$4.33 Million2.16% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$4.08 Million0.1% of portfolio
-
Orbimed Advisors LLC San Diego, CA2MShares$3.26 Million0.13% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $48.9M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...